Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers

Abstract

Our translational study assessed global fecal miRNA changes of patients with CD and relevant preclinical models. These fecal miRNAs show promise as translational and clinically useful noninvasive biomarkers for mechanistic investigation of intestinal pathophysiology, including monitoring of disease progression.